Proteome Sciences (LON:PRM) Posts Earnings Results

Proteome Sciences (LON:PRM) released its quarterly earnings results on Wednesday. The company reported GBX (1.04) EPS for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 376 million for the quarter. Proteome Sciences had a negative net margin of 73.62% and a positive return on equity of 44.15%.

Proteome Sciences Stock Performance

LON:PRM opened at GBX 1.25 on Thursday. Proteome Sciences has a twelve month low of GBX 1.25 and a twelve month high of GBX 4.40. The company has a market cap of £4.37 million, a P/E ratio of -1.10 and a beta of 0.07. The company’s 50-day moving average price is GBX 1.69 and its 200-day moving average price is GBX 2.03. The company has a current ratio of 0.11, a quick ratio of 0.37 and a debt-to-equity ratio of -179.32.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.